Exosomes derived from chemoresistant CRC cells could transfer ciRS-122 across cells and promote cell glycolysis to reduce drug susceptibility in chemosensitive cells through the miR-122-PKM2 axis 41. This evidence concerns the gene PKM and colorectal carcinoma.